Dr. Csaba Juhasz, MD, PhD
Claim this profileKarmanos Cancer Institute
Studies Neuroendocrine Tumors
Studies Brain Tumor
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Csaba Juhasz, MD, PhD is currently running
F-Tryptophan PET/CT Imaging
for Cancer
Imaging procedures such as 1-(2-\[18F\]FLUOROETHYL)-L-Tryptophan PET/CT in patients with cancers may help doctors assess a patient's response to treatment and help plan the best treatment in the future. The purpose is to see if there can be a better differentiation of tumor and non-tumor tissue where the tumor tissue has a higher uptake of Tryptophan.
Recruiting1 award Phase 1
Neuroimaging
for Sturge-Weber Syndrome
In this project the accuracy of a novel, rapid magnetic resonance imaging (MRI) approach to detect brain abnormalities in patients with Sturge-Weber syndrome (SWS) will be tested; this new imaging approach, that can create multiple types of MR images in about 5 minutes, without contrast administration (and sedation even in young children), can be also readily applied in other pediatric brain disorders in the future. The investigators will also study how advanced MRI, including susceptibility-weighted and diffusion tensor imaging can detect detailed signs of brain vascular and neuronal reorganization that helps improve neurological and cognitive outcome of children and young adults with SWS, who could benefit from targeted interventions in the future to minimize neurocognitive deficits in affected patients. All enrolled subjects will undergo advanced brain MRI and neurocognitive evaluation to achieve these goals.
Recruiting1 award N/A5 criteria
More about Csaba Juhasz, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Csaba Juhasz, MD, PhD has experience with
- 1-(2-[18F]FLUOROETHYL)-L-Tryptophan
- Brain Magnetic Resonance Imaging
- Neuro-psychology Testing
Breakdown of trials Csaba Juhasz, MD, PhD has run
Neuroendocrine Tumors
Brain Tumor
Breast Cancer
Rectal Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Csaba Juhasz, MD, PhD specialize in?
Csaba Juhasz, MD, PhD focuses on Neuroendocrine Tumors and Brain Tumor. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are undergoing treatment.
Is Csaba Juhasz, MD, PhD currently recruiting for clinical trials?
Yes, Csaba Juhasz, MD, PhD is currently recruiting for 2 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Csaba Juhasz, MD, PhD has studied deeply?
Yes, Csaba Juhasz, MD, PhD has studied treatments such as 1-(2-[18F]FLUOROETHYL)-L-Tryptophan, Brain Magnetic Resonance Imaging, Neuro-psychology Testing.
What is the best way to schedule an appointment with Csaba Juhasz, MD, PhD?
Apply for one of the trials that Csaba Juhasz, MD, PhD is conducting.
What is the office address of Csaba Juhasz, MD, PhD?
The office of Csaba Juhasz, MD, PhD is located at: Karmanos Cancer Institute, Detroit, Michigan 48201 United States. This is the address for their practice at the Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.